Exact Mass: 496.2573
Exact Mass Matches: 496.2573
Found 500 metabolites which its exact mass value is equals to given mass value 496.2573
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Leukotriene D4
Leukotriene D4 (LTD4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. LTD4 is a pro-inflammatory mediator known to mediate its effects through specific cell-surface receptors belonging to the G-protein-coupled receptor family, namely the high-affinity CysLT1 (cysteinyl leukotriene 1) receptor. LTD4 is present at high levels in many inflammatory conditions, and areas of chronic inflammation have an increased risk for subsequent cancer development. LTD4 is associated with the pathogenesis of several inflammatory disorders, such as asthma and inflammatory bowel disease. Exposure to LTD4 increases survival and proliferation in intestinal epithelial cells. CysLT1 regulator is up-regulated in colon cancer tissue and LTD4 signalling facilitates the survival of cancer cells. LTD4 could reduce apoptosis in non-transformed epithelial cells. LTD4 causes up-regulation of beta-catenin through the CysLT1 receptor, PI3K (phosphoinositide 3-kinase), and GSK-3β (glycogen synthase kinase 3β). LTD4 induces beta-catenin translocation to the nucleus and activation of TCF/LEF family of transcription factors. LTD4 causes accumulation of free beta-catenin in non-transformed intestinal epithelial cells through the CysLT1 receptor, and this accumulation is dependent upon the activation of PI3K as well as GSK-3β inactivation (PMID: 16042577, 12607939). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent and are able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis through receptor-mediated G-protein linked signaling pathways. Leukotriene D4 (LTD4) is a cysteinyl leukotriene a family of potent inflammatory mediators. LTD4 is a pro-inflammatory mediator known to mediate its effects through specific cell-surface receptors belonging to the G-protein-coupled receptor family, namely the high-affinity CysLT1 (cysteinyl leukotriene 1) receptor. LTD4 is present at high levels in many inflammatory conditions, and areas of chronic inflammation have an increased risk for subsequent cancer development; LTD4 is associated with the pathogenesis of several inflammatory disorders, such as asthma and inflammatory bowel disease. Exposure to LTD4 increases survival and proliferation in intestinal epithelial cells. CysLT1 regulator is up-regulated in colon cancer tissue and LTD4 signalling facilitates the survival of cancer cells. LTD4 could reduce apoptosis in non-transformed epithelial cells. LTD4 causes up-regulation of b-catenin through the CysLT1 receptor, PI3K (phosphoinositide 3-kinase) and GSK-3b (glycogen synthase kinase 3b). LTD4 induces b-catenin translocation to the nucleus and activation of TCF/LEF family of transcription factors. LTD4 causes accumulation of free b-catenin in non-transformed intestinal epithelial cells through the CysLT1 receptor, and this accumulation is dependent upon the activation of PI3K as well as GSK-3b inactivation. (PMID: 16042577, 12607939)
6-[2-Amino-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid
O-beta-D-Glucopyranoside-(ent-11alpha,16alpha)-11-Hydroxy-15-oxo-kauranoic acid
6alpha-19-[3-(4-Hydroxyphenyl)propanoyl] ester:6,19-Dihydroxy-3-oxo-5(10),13-halimadien-15,16-olide
12-O-beta-D-glucopyranosyl-3,11,16-trihydroxyabieta-8,11,13-triene
18-O-beta-D-glucopyranosyl,19-hydroxy-5alpha,10beta-neo-cleroda-3,13(14)-dien-16,15-butenolide|soulidioside
(-)-19-beta-D-glucopyranosyl 6,7-dihydroxy-kaurenoate
(1S*,2S*,3S*,4R*,4aR*,5R*,6R*,9R*,10S*,12R*,12aS*)-tetradecahydro-1,6,10-trimethyl-4-(1-methylethyl)-5,12:6,9-diepoxybenzocyclododecene-1,2,3,9-tetrol 1,2,3-triacetate|massileunicellin C
1-O-decanoyl-6-O-D-beta-glucopyranosyl-beta-D-glucopyranose|6-O-(beta-D-glucopyranosyl)-1-O-decanoyl-beta-D-glucopyranose|nonioside R
15-O-acetyl-3-O-benzoylcharaciol-5beta,6beta-oxide
21,25,26,27-tetranorapoeupha-6alpha-methoxy-7alpha-acetoxy-2,14,20(22)-trien-1,12,16,23-tetraone|21,25,26,27-tetranorapotirucalla-6alpha-methoxy-7alpha-acetoxy-2,14,20(22)-trien-1,12,16,23-tetraone|meliatetraone
13S-hydroxy-labda-7,14-dien-6-oxo-19-oic acid beta-D-glucopyranoside|cathargyroside A
beta-D-glucopyranosyl (13S)-13-hydroxy-7-oxo-labda-8,14-diene-18-oate
15-hydroxy-labda-7,13E-dien-6-oxo-19-oic acid beta-D-glucopyranoside|cathargyroside B
macropodumine J|methyl rel-(3R,6R,10aS,11S,12aS)-5-(acetyloxy)-5a-[(acetyloxy)methyl]-12b-cyano-2,3,3a,5,5a,6,7,8,9,10,10a,11,12,12b-tetradecahydro-3-methyl-4H-1,6-methanocyclopenta[1,8]azuleno[4,3a-g]indole-11-carboxylate
(16S)-dihydrohyalic acid beta-glucopyranosyl ester
Val His Ile Glu
Andropanoside
Andropanoside is a natural product found in Andrographis paniculata with data available.
[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 8-methylnonanoate
C26H40O9_2,4a,6-Trihydroxy-8-isopropyl-1,1-dimethyl-2,3,4,4a,5,10,11,11a-octahydro-1H-dibenzo[a,d][7]annulen-7-yl beta-D-glucopyranoside
LTD4-[d5]
CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0222.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0222.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0222.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000153.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000153.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000153.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000153.mzML; PROCESSING averaging of repeated ion fragments at 40.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000153.mzML; PROCESSING averaging of repeated ion fragments at 30.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000153.mzML; PROCESSING averaging of repeated ion fragments at 20.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ]
[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 8-methylnonanoate [IIN-based on: CCMSLIB00000846747]
[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 8-methylnonanoate [IIN-based: Match]
Ala Phe Phe Ile
Ala Phe Phe Leu
Ala Phe Ile Phe
Ala Phe Leu Phe
Ala His Asn Arg
Ala His Arg Asn
Ala Ile Phe Phe
Ala Leu Phe Phe
Ala Asn His Arg
Ala Asn Arg His
Ala Arg His Asn
Ala Arg Asn His
Asp His Ile Ile
Asp His Ile Leu
Asp His Leu Ile
Asp His Leu Leu
Asp Ile His Ile
Asp Ile His Leu
Asp Ile Ile His
Asp Ile Leu His
Asp Leu His Ile
Asp Leu His Leu
Asp Leu Ile His
Asp Leu Leu His
Glu His Ile Val
Glu His Leu Val
Glu His Val Ile
Glu His Val Leu
Glu Ile His Val
Glu Ile Val His
Glu Leu His Val
Glu Leu Val His
Glu Val His Ile
Glu Val His Leu
Glu Val Ile His
Glu Val Leu His
Phe Ala Phe Ile
Phe Ala Phe Leu
Phe Ala Ile Phe
Phe Ala Leu Phe
Phe Phe Ala Ile
Phe Phe Ala Leu
Phe Phe Ile Ala
Phe Phe Leu Ala
Phe Ile Ala Phe
Phe Ile Phe Ala
Phe Leu Ala Phe
Phe Leu Phe Ala
Gly His Gln Arg
Gly His Arg Gln
Gly Gln His Arg
Gly Gln Arg His
Gly Arg His Gln
Gly Arg Gln His
His Ala Asn Arg
His Ala Arg Asn
His Asp Ile Ile
His Asp Ile Leu
His Asp Leu Ile
His Asp Leu Leu
His Glu Ile Val
His Glu Leu Val
His Glu Val Ile
His Glu Val Leu
His Gly Gln Arg
His Gly Arg Gln
His Ile Asp Ile
His Ile Asp Leu
His Ile Glu Val
His Ile Ile Asp
His Ile Leu Asp
His Ile Met Pro
His Ile Pro Met
His Ile Val Glu
His Leu Asp Ile
His Leu Asp Leu
His Leu Glu Val
His Leu Ile Asp
His Leu Leu Asp
His Leu Met Pro
His Leu Pro Met
His Leu Val Glu
His Met Ile Pro
His Met Leu Pro
His Met Pro Ile
His Met Pro Leu
His Asn Ala Arg
His Asn Arg Ala
His Pro Ile Met
His Pro Leu Met
His Pro Met Ile
His Pro Met Leu
His Gln Gly Arg
His Gln Arg Gly
His Arg Ala Asn
His Arg Gly Gln
His Arg Asn Ala
His Arg Gln Gly
His Val Glu Ile
His Val Glu Leu
His Val Ile Glu
His Val Leu Glu
Ile Ala Phe Phe
Ile Asp His Ile
Ile Asp His Leu
Ile Asp Ile His
Ile Asp Leu His
Ile Glu His Val
Ile Glu Val His
Ile Phe Ala Phe
Ile Phe Phe Ala
Ile His Asp Ile
Ile His Asp Leu
Ile His Glu Val
Ile His Ile Asp
Ile His Leu Asp
Ile His Met Pro
Ile His Pro Met
Ile His Val Glu
Ile Ile Asp His
Ile Ile His Asp
Ile Leu Asp His
Ile Leu His Asp
Ile Met His Pro
Ile Met Pro His
Ile Pro His Met
Ile Pro Met His
Ile Thr Thr Tyr
Ile Thr Tyr Thr
Ile Val Glu His
Ile Val His Glu
Ile Tyr Thr Thr
Leu Ala Phe Phe
Leu Asp His Ile
Leu Asp His Leu
Leu Asp Ile His
Leu Asp Leu His
Leu Glu His Val
Leu Glu Val His
Leu Phe Ala Phe
Leu Phe Phe Ala
Leu His Asp Ile
Leu His Asp Leu
Leu His Glu Val
Leu His Ile Asp
Leu His Leu Asp
Leu His Met Pro
Leu His Pro Met
Leu His Val Glu
Leu Ile Asp His
Leu Ile His Asp
Leu Leu Asp His
Leu Leu His Asp
Leu Met His Pro
Leu Met Pro His
Leu Pro His Met
Leu Pro Met His
Leu Thr Thr Tyr
Leu Thr Tyr Thr
Leu Val Glu His
Leu Val His Glu
Leu Tyr Thr Thr
Met His Ile Pro
Met His Leu Pro
Met His Pro Ile
Met His Pro Leu
Met Ile His Pro
Met Ile Pro His
Met Leu His Pro
Met Leu Pro His
Met Pro His Ile
Met Pro His Leu
Met Pro Ile His
Met Pro Leu His
Asn Ala His Arg
Asn Ala Arg His
Asn His Ala Arg
Asn His Arg Ala
Asn Arg Ala His
Asn Arg His Ala
Pro His Ile Met
Pro His Leu Met
Pro His Met Ile
Pro His Met Leu
Pro Ile His Met
Pro Ile Met His
Pro Leu His Met
Pro Leu Met His
Pro Met His Ile
Pro Met His Leu
Pro Met Ile His
Pro Met Leu His
Gln Gly His Arg
Gln Gly Arg His
Gln His Gly Arg
Gln His Arg Gly
Gln Arg Gly His
Gln Arg His Gly
Arg Ala His Asn
Arg Ala Asn His
Arg Gly His Gln
Arg Gly Gln His
Arg His Ala Asn
Arg His Gly Gln
Arg His Asn Ala
Arg His Gln Gly
Arg Asn Ala His
Arg Asn His Ala
Arg Gln Gly His
Arg Gln His Gly
Thr Ile Thr Tyr
Thr Ile Tyr Thr
Thr Leu Thr Tyr
Thr Leu Tyr Thr
Thr Thr Ile Tyr
Thr Thr Leu Tyr
Thr Thr Tyr Ile
Thr Thr Tyr Leu
Thr Tyr Ile Thr
Thr Tyr Leu Thr
Thr Tyr Thr Ile
Thr Tyr Thr Leu
Val Glu His Ile
Val Glu His Leu
Val Glu Ile His
Val Glu Leu His
Val His Glu Ile
Val His Glu Leu
Val His Leu Glu
Val Ile Glu His
Val Ile His Glu
Val Leu Glu His
Val Leu His Glu
Tyr Ile Thr Thr
Tyr Leu Thr Thr
Tyr Thr Ile Thr
Tyr Thr Leu Thr
Tyr Thr Thr Ile
Tyr Thr Thr Leu
Leukotriene D4
A leukotriene that is (7E,9E,11Z,14Z)-icosa-7,9,11,14-tetraenoic acid substituted by a hydroxy group at position 5 (5S) and a L-cysteinylglycinyl group at position 6 (6R).
1,1,3,3,3,3-hexamethylindotricarbocyanine tetrafluoroborate
(4R,15R)-11β,15-Dihydroxykaur-16-en-18-oic acid [β-D-glucopyranosyl] ester
4-Methyl-N-(3-Morpholin-4-Ylphenyl)-3-(3-Piperidin-4-Yl-1,2-Benzisoxazol-6-Yl)benzamide
9-[(E)-4-[(6S)-2-[(1S,2S,3S)-1,3-dihydroxy-2-methylbutyl]-7-oxo-3,4-dihydro-2H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyl]oxynonanoic acid
9-[(E)-4-[(6S)-4-hydroxy-3-[[3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]-5-oxo-2H-pyran-6-yl]-3-methylbut-2-enoyl]oxynonanoic acid
6-[2-Amino-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(1,4,13-trihydroxy-12,12-dimethyl-6-propan-2-yl-5-tricyclo[9.4.0.03,8]pentadeca-3,5,7-trienyl)oxy]oxane-3,4,5-triol
3-(3-fluorophenyl)-1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-pent-1-ynyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
(8R,9R,10R)-10-(hydroxymethyl)-N-(4-methoxyphenyl)-9-[4-[2-(2-pyridinyl)ethynyl]phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
[(2R,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 8-methylnonanoate
3-(3-fluorophenyl)-1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-pent-1-ynyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
(1S,9R,10R,11R)-12-(cyclopropylmethyl)-10-(hydroxymethyl)-6-oxo-5-[(E)-2-phenylethenyl]-N-(pyridin-2-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(2R,3R,3aS,9bS)-7-(1-cyclopentenyl)-N-[3-(dimethylamino)propyl]-3-(hydroxymethyl)-6-oxo-1-(3,3,3-trifluoropropyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(8R,9R,10S)-9-[4-(3-cyanophenyl)phenyl]-10-(hydroxymethyl)-N-(2-methoxyphenyl)-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
(8S,9R,10R)-9-[4-(3-cyanophenyl)phenyl]-10-(hydroxymethyl)-N-(2-methoxyphenyl)-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
(8R,9R,10R)-9-[4-(3-cyanophenyl)phenyl]-10-(hydroxymethyl)-N-(2-methoxyphenyl)-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
[(E)-[(1R,4aR,4bS,8aS,10aS)-1-[2-[(2S)-2-methoxy-5-oxo-2H-furan-4-yl]ethyl]-4b,8,8,10a-tetramethyl-1,3,4,4a,5,6,7,8a,9,10-decahydrophenanthren-2-ylidene]methyl] hydrogen sulfate
[(E)-[(1R,4aR,4bS,8aS,10aS)-1-[2-[(2R)-2-methoxy-5-oxo-2H-furan-4-yl]ethyl]-4b,8,8,10a-tetramethyl-1,3,4,4a,5,6,7,8a,9,10-decahydrophenanthren-2-ylidene]methyl] hydrogen sulfate
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridine-2-carbonyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(3-pyridinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(3-pyridinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(3-pyridinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
(2S,3S,3aR,9bR)-7-[4-[dimethylamino(oxo)methyl]phenyl]-3-(hydroxymethyl)-N-(2-methoxyethyl)-6-oxo-1-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridine-2-carbonyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(pyridine-3-carbonyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
(2S,3S,3aR,9bR)-7-(4-fluorophenyl)-3-(hydroxymethyl)-6-oxo-2-(piperidine-1-carbonyl)-N-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-1-carboxamide
(2R,3R,3aS,9bS)-N-[3-(dimethylamino)propyl]-3-(hydroxymethyl)-7-(2-methoxyphenyl)-6-oxo-1-propanoyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-7-[4-(dimethylcarbamoyl)phenyl]-3-(hydroxymethyl)-N-(2-methoxyethyl)-6-oxo-1-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
1-[[(2S,3R)-8-(1-cyclopentenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(3-fluorophenyl)-1-methylurea
1-[[(2S,3S)-8-(1-cyclopentenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(3-fluorophenyl)-1-methylurea
1-[[(2R,3S)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(3-fluorophenyl)-1-methylurea
1-[[(2R,3S)-8-(1-cyclopentenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(3-fluorophenyl)-1-methylurea
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
1-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
(2R,3R,3aS,9bS)-7-(4-fluorophenyl)-3-(hydroxymethyl)-6-oxo-2-[oxo(1-piperidinyl)methyl]-N-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-1-carboxamide
(8R,9S,10R)-9-[4-(3-cyanophenyl)phenyl]-10-(hydroxymethyl)-N-(2-methoxyphenyl)-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
(8S,9R,10S)-9-[4-(3-cyanophenyl)phenyl]-10-(hydroxymethyl)-N-(2-methoxyphenyl)-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
(8S,9S,10R)-9-[4-(3-cyanophenyl)phenyl]-10-(hydroxymethyl)-N-(2-methoxyphenyl)-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
1-[[(2R,3R)-8-(1-cyclopentenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(3-fluorophenyl)-1-methylurea
3-(3-fluorophenyl)-1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-pent-1-ynyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-pent-1-ynyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-pent-1-ynyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-pent-1-ynyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
1-[[(2R,3R)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(3-fluorophenyl)-1-methylurea
1-[[(2S,3S)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(3-fluorophenyl)-1-methylurea
1-[[(2S,3R)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(3-fluorophenyl)-1-methylurea
3-(3-fluorophenyl)-1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-pent-1-ynyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-pent-1-ynyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(3-pyridinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(3-pyridinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
1-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-[(4-phenoxyphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-morpholinyl)ethanone
(2S,3S,3aR,9bR)-7-(1-cyclopentenyl)-N-[3-(dimethylamino)propyl]-3-(hydroxymethyl)-6-oxo-1-(3,3,3-trifluoropropyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(8S,9S,10S)-9-[4-(3-cyanophenyl)phenyl]-10-(hydroxymethyl)-N-(2-methoxyphenyl)-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
(8R,9S,10S)-9-[4-(3-cyanophenyl)phenyl]-10-(hydroxymethyl)-N-(2-methoxyphenyl)-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
(1R,9S,10S,11S)-N-[3-(dimethylamino)propyl]-12-(2-fluorobenzoyl)-10-(hydroxymethyl)-6-oxo-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1S,9R,10R,11R)-N-[3-(dimethylamino)propyl]-12-(2-fluorobenzoyl)-10-(hydroxymethyl)-6-oxo-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
eoxin D4
A leukotriene that is the 14R-(S-cysteinylglycyl),15S-hydroxy derivative of (5Z,8Z,10E,12E)-icosa-7,9,11,14-tetraenoic acid.
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,4s,5s,6r,9s,10r,12r,13r)-6,12-dihydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate
(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,2s,3s,4s,5s,9r,10s,13s)-2,3-dihydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate
(1s,3br,4s,5r,5as,9ar,9bs,11as)-5-methoxy-3b,6,6,9a,11a-pentamethyl-2,9,11-trioxo-1-[(1z)-3-oxobut-1-en-1-yl]-1h,4h,5h,5ah,9bh,10h-cyclopenta[a]phenanthren-4-yl acetate
2-{[4,7-dihydroxy-2-(1-hydroxypropan-2-yl)-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4r,5r,6s)-2-{[(2s,3r,4s,5r,6r)-2-[(6,7-dihydroxy-3,7-dimethyloct-1-en-3-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-6-methyloxane-3,4,5-triol
2-ethenyl-6,7-dihydroxy-2,4b,8-trimethyl-8-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1,3,4,4a,5,6,7,8a-octahydrophenanthren-9-one
3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 11,15-dihydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate
3-{2-[(1r,4ar,5r,6r,8as)-6-hydroxy-5,8a-dimethyl-2-methylidene-5-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-hexahydro-1h-naphthalen-1-yl]ethyl}-5h-furan-2-one
(1r,2s,4s,4as,5s,5's,6r,8as)-4,6-bis(acetyloxy)-5'-(2-hydroxyethyl)-2,5,5',8a-tetramethyl-3-oxo-hexahydrospiro[naphthalene-1,2'-oxolan]-5-ylmethyl acetate
[(1s,2r,4as,8s,8ar)-2,8-bis(acetyloxy)-5-(3,5-dihydroxy-3-methylpentyl)-1,4a,6-trimethyl-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl]methyl acetate
6-[(7-ethenyl-2,3-dihydroxy-1,4a,7-trimethyl-3,4,4b,5,6,8,10,10a-octahydro-2h-phenanthren-1-yl)methoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
3a-(acetyloxy)-13-hydroxy-2,5,8,8-tetramethyl-12-methylidene-4,9-dioxo-1h,2h,3h,7h,10h,11h,13h,13ah-cyclopenta[12]annulen-1-yl benzoate
3-(4-hydroxy-2-methyl-6-oxocyclohex-1-en-1-yl)-7-methyl-6,8-dioxoisochromen-7-yl 2,4-dimethyldec-2-enoate
7-ethenyl-2,3-dihydroxy-1,4a,7-trimethyl-1-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2,3,4,5,6,8,10,10a-octahydrophenanthren-9-one
3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 12,15-dihydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate
5-methoxy-3b,6,6,11a-tetramethyl-2,9,11-trioxo-1-[(2z)-4-oxopent-2-en-2-yl]-1h,4h,5h,5ah,9ah,9bh,10h-cyclopenta[a]phenanthren-4-yl acetate
(1r,3s,6s,8r,10r,13r,14r)-3,6-dihydroxy-5,5,14-trimethyl-9-methylidene-14-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tetracyclo[11.2.1.0¹,¹⁰.0³,⁸]hexadecan-4-one
methyl (1r,2e,4s,5r,9r,11r,12r)-1-hydroxy-5-isopropyl-8,12-dimethyl-11-{[(2e)-3-(1-methylimidazol-4-yl)prop-2-enoyl]oxy}-15-oxatricyclo[10.2.1.0⁴,⁹]pentadeca-2,7,13-triene-2-carboxylate
18,19-dihydroxy-3,13-clerodadien-16,15-olide; ent-form,18-o-beta-d-glucopyranoside
{"Ingredient_id": "HBIN002077","Ingredient_name": "18,19-dihydroxy-3,13-clerodadien-16,15-olide; ent-form,18-o-beta-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C26H40O9","Ingredient_Smile": "NA","Ingredient_weight": "496.59","OB_score": "NA","CAS_id": "194411-26-2","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9260","PubChem_id": "NA","DrugBank_id": "NA"}
3,4-dihydro-excelsin
{"Ingredient_id": "HBIN007368","Ingredient_name": "3,4-dihydro-excelsin","Alias": "NA","Ingredient_formula": "C26H40O9","Ingredient_Smile": "CCCC(C)C(=O)OC1C2C(C(C3(C4C2(CO3)C(CC5C4(C(C(CC5C)O)O)C)OC1=O)O)O)C","Ingredient_weight": "496.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5611","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101232102","DrugBank_id": "NA"}